How many investments has SynBioVen made?

SynBioVen has 7 tracked investments, including 2 dated in the last 24 months.

What stage does SynBioVen invest at?

SynBioVen invests at the Pre-Seed, Seed, Series A stages.

Where is SynBioVen located?

SynBioVen is headquartered in London, GB.

Who does SynBioVen co-invest with?

SynBioVen most often shares deals with Future Planet Capital, Clay Capital, Hoxton Ventures, among 20 tracked co-investors.

SynBioVen

Venture capital

London · Pre-Seed–Series A · 4 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

Find your way into SynBioVen

Your email: who you already know at SynBioVen, and who your contacts know
2nd- and 3rd-degree connections: people you know who worked, studied or invested with the SynBioVen team
Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

✨ Fox Verdict

Investment thesis

SynBioVen invests at the earliest stages — proof-of-concept, pre-seed and seed — in synthetic biology ventures. The firm believes synthetic biology will power the next industrial revolution and the transition to a net-zero economy, with UK companies leading the way. Beyond capital, it offers portfolio companies access to a network of experts spanning synthetic biology research, business development and financing, a dedicated technical team at SynbiCITE, and use of the London Biofoundry R&D hub in West London to help startups de-risk and scale.

Invests inAgTech AI & Machine Learning Biotech Climate Tech Deep Tech FoodTech IoT Medical Devices New Materials London United Kingdom

Source: firm website, verified Aug 3, 2026.

Leave your own feedback

Stage

Pre-Seed–Series A

London, GB

Instruments

Equity

Founded

2022

Last 12 months

1 investment

Tracked investments

Team · 4 people

from the firm's website

Sir David Harding

Founder and CEO of Winton Group Limited, a research-based investment management firm specializing in statistical and mathematical inference in financial markets.

Lord David Willetts· FRS

Former UK Minister for Universities and Science, author of The Eight Great Technologies Strategy and creator of the Synthetic Biology Leadership Council.

Paul Freemont· Prof

Co-founder of the Imperial College Synthetic Biology Cluster and co-founder/co-director of SynbiCITE, and chair of the Global Biofoundry Alliance.

Richard Kitney· Prof, OBE

Co-founder of the Imperial College Synthetic Biology Cluster and co-founder/co-director of SynbiCITE, and a member of the Ministerial Leadership Council for Synthetic Biology.

What they invest in

from 6 of 7 portfolio companies

Biotech ×6AI & Machine Learning ×5Cleantech ×2AgTech ×1Circular Economy ×1Climate Tech ×1Deep Tech ×1FoodTech ×1

HQs:United Kingdom×3United States×1

Investments · 7 tracked

founders shown can be your intro path

By year:2026 · 1 2025 · 1 2023 · 1 2022 · 14 dated

CHAIN Biotechnology Seedchainbiotech.com

Partner Sir David Harding· solo GP

Co-investorsFuture Planet Capital Oxford Investment Opportunity Network (OION)

Colorifix Limitedcolorifix.com in

Colorifix uses engineered microorganisms to produce, deposit, and fix dyes on textiles through a biological fermentation process, aiming to reduce the environmental impact of textile dyeing.

BiotechCircular EconomyCleantechClimate TechNew MaterialsNorwich, GB

Orr Yarkoni(Founder)in

Partner Sir David Harding· solo GP

Co-investorsGOLDWIN VENTURE PARTNERS Regeneration.VC

Eden Bioeden.bioNov 2022

Eden Bio develops machine-learning technology for genetic engineering and protein yield optimization across food, pharmaceutical, and biofuel industries.

AI & Machine LearningBiotech

Partner Sir David Harding· solo GP

Co-investorsUnruly Capital SARAS CAPITAL Semantic Ventures

Multusmultus.bio inJan 2023 · $9.5M

Multus designs cell culture media for the industrial bioeconomy, applying AI, robotics, and biological expertise to media formulation.

AI & Machine LearningBiotechDeep TechFoodTechLondon, GB

Cai Linton(Founder)in

Partner Sir David Harding· solo GP

Co-investorsAsahi Kasei Corporate Venture Capital Big Idea Ventures Zero Carbon Capital Mandi Ventures Marinya Capital SOSV

Resurrect Bioresurrect.bio inFeb 2026 · $8.1M

Resurrect Bio develops genetic disease-resistance traits for crops by restoring plant R-genes, using its FloraFold AI platform and rapid in-planta screening for trait discovery.

AgTechAI & Machine LearningBiotechLondon, GB

Cian Duggan(CEO & Co-Founder)inTolga Bozkurt(Co-Founder)in Sophien Kamoun(Co-Founder)in

Partner Sir David Harding· solo GP

Co-investorsCalculus Capital Ltd.Future Planet Capital UK Innovation & Science Seed Fund AgFunder Pymwymic

Scindoscindo.bio in 𝕏Sep 2025 · $5.4M

Scindo uses AI and machine learning to discover and design novel enzymes for sustainable manufacturing.

AI & Machine LearningBiotechCleantech

Partner Sir David Harding· solo GP

Co-investorsClay Capital Farvatn Venture PINC AgFunder Kadmos Capital SOSV

Valink Therapeuticsvalinktx.com in

Valink Therapeutics develops bispecific antibody-drug conjugates (ADCs) for therapeutic applications, combining high-throughput discovery, antibody engineering, and medicinal chemistry capabilities.

AI & Machine LearningBiotechHealthtechMedical DevicesBoston, US

Arne Scheu(Co-Founder & CEO)in Irsyad Khairil(Co-Founder & CTO)in

Partner Sir David Harding· solo GP

Co-investorsHoxton Ventures LongeVC Metaplanet Oxonian Ventures P53 Invest Ventac Partners +8 more

Portfolio news

latest coverage across their companies

UK AgriBioTech startup Resurrect Bio closes €8.8 million Series A to develop disease-resistant crops | EU-Startups

Resurrect Bio · eu-startups.com · May 14, 2026

Valink Therapeutics Closes $11.8M Pre-A Financing Round

Valink Therapeutics · finsmes.com · Oct 20, 2025

Scindo Raises £4M in Funding

Scindo · finsmes.com · Sep 23, 2025

Principals & officers · per Companies House

what is this? ⓘ

Paul Simon Freemont

Director · British · since 2022

David Winton Harding

Director · British · since 2022

Richard Ian Professor Kitney

Director · British · since 2022

David Lindsay Willetts

Director · British · since 2022

Ownership & control

David Winton Harding — 50–75% of shares, 50–75% of voting rights, right to appoint and remove directors

Frequently asked questions

How many investments has SynBioVen made?: SynBioVen has 7 tracked investments, including 2 dated in the last 24 months.
What stage does SynBioVen invest at?: SynBioVen invests at the Pre-Seed, Seed, Series A stages.
What sectors does SynBioVen focus on?: SynBioVen focuses on AgTech, AI & Machine Learning, Biotech, Climate Tech, Deep Tech, FoodTech, IoT, Medical Devices, New Materials.
Where is SynBioVen located?: SynBioVen is headquartered in London, GB.
Who does SynBioVen co-invest with?: SynBioVen most often shares deals with Future Planet Capital, Clay Capital, Hoxton Ventures, among 20 tracked co-investors.

Similar investors

Qbic Fund

Qbic is an inter-university venture capital fund that backs the transformation of technological breakthroughs from its academic and research partners into sustainable businesses.

Everywhere Ventures

Everywhere Ventures is an early-stage venture firm that writes pre-seed checks and is backed by a community of founder and operator LPs.

$250K

Seventure Partners

Seventure Partners is a European venture capital firm backing innovative companies across life sciences and digital technologies, with additional focus areas in sport & performance and the blue economy.

BDC Fund Investments (Fund-of-Funds)

This page is the analysis and research library of BDC (Business Development Bank of Canada), listing studies, surveys and reports on issues affecting Canadian small and medium-sized businesses and the venture capital landscape.